Stijn van Rompay

Stijn Van Rompay is an accomplished executive in the pharmaceutical and financial sectors, currently serving as CEO and reference shareholder of Hyloris Pharmaceuticals, a Belgian specialty biopharma company, since 2014. Van Rompay has extensive experience as a board member and reference shareholder at PE Group, which specializes in private equity investments. Additional roles include Chairman of EXO Biologics and member of the board at IMCYSE, a firm focused on novel immune therapies. Van Rompay previously held leadership positions at Alter Pharma, Uteron Pharma, and Docpharma, overseeing the development and commercialization of pharmaceuticals in various therapeutic areas. An alumnus of the University of Antwerp with a Master's degree in Economics, Stijn Van Rompay has demonstrated a strong commitment to addressing unmet medical needs through innovative solutions.